Polymerase chain reaction market
Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, and Others) and Reagents and Consumables)), by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
- Jul 2022
- CMI1546
- 150 Pages
- Excel & Pdf
- Medical Devices
Polymerase chain reaction (PCR) is used to amplify a specific segment of DNA through a thermal cycling protocol. Continuous technological advancement in the field of polymerase chain reaction are aimed to improve specificity, scalability and reliability in DNA amplification and thereby creating millions of amplicons of a target sequence in a short period of time. PCR is used for various applications, including the detection of pathogenic bacteria, disease diagnosis, molecular and genetic research, forensic DNA profiling, and parental testing. Rapid technological advancement in the polymerase chain reaction to deliver highly sensitive and optimized detection instrument, increasing prevalence of chronic and infectious disease, and growing research funding in gene therapy and molecular testing is expected to drive growth of the global polymerase chain reaction market over the forecast period.
The global polymerase chain reaction market is estimated to be valued at US$ 5,627.9 million in 2022 and is expected to exhibit a CAGR of 8.9% during the forecast period (2022-2030).
Figure 1. Global Polymerase Chain Reaction Market Share (%), by Product Type, 2022
Increasing numbers of product launches in polymerase chain reaction are expected to drive growth of the global polymerase chain reaction market
Key players in the polymerase chain reaction market are engaged in launching advanced and novel PCR instruments and consumables, which will allows rapid and easy nucleic acid amplification. For instance, in October 2017, Diatech Pharmacogenetics S.R.L., a provider of molecular diagnostic tools for precision medicine launched easyPGX: a ready-to-use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma.
Figure 2.Global Polymerase Chain Reaction Market Share (%), by Region, 2022
Increasing prevalence of chronic and infectious disease are driving growth of the global polymerase chain reaction market
Polymerase chain reaction is increasingly used in clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. For instance, in March 2022, according to data published by Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by the 2027. The most common forms of cancer affecting the people of India are breast cancer, cervical cancer, and oral cancer. Furthermore, in May 2022, according to data published by National Center for Biotechnology Information, projected cancer burden in India for 2021 was 26.7 million and expected to increase to 29.8 million in 2025. In 2021 highest burden was in the north (2408 DALYsAMI per 100,000) and northeastern (2177 DALYsAMI per 100,000) regions of the India and higher among males. More than 40% of the total cancer burden was contributed by the seven leading cancer sites — lung (10.6%), breast (10.5%), oesophagus (5.8%), mouth (5.7%), stomach (5.2%), liver (4.6%), and cervix uteri (4.3%).
Polymerase Chain Reaction Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2022: | US$ 5,627.9 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 8.9% | 2030 Value Projection: | US$ 11,142.2 Mn |
Geographies covered : |
|
||
Segments covered: |
|
||
Companies covered: |
F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Global Polymerase Chain Reaction Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a positive impact on the global polymerase chain reaction market, owing to application of polymerase chain reaction technique in detection of covid-19. For instance, in January 2020, according to data published by PubMed, zoonotic transmission of SARS coronavirus from animals to humans was detected using classical Reverse Transcription–Polymerase Chain Reaction (RT-PCR) assays that target a highly conserved sequence among coronaviruses. Reverse Transcription Polymerase Chain Reaction (RT-PCR) assays was firstly used to identify coronaviruses in bats.
Global Polymerase Chain Reaction Market: Key Developments
In March 2022, according to the U.S. Food and Drug Administration (FDA), a new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA). Rapid Polymerase Chain Reaction (PCR) test was developed in March 2022 at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being commercialized by Northwestern spinoff company, Minute Molecular Diagnostics.
Global Polymerase Chain Reaction Market: Restraint
The major factors that hinder growth of the global polymerase chain reaction market include advances in research are leading to generation of various alternative nucleic acid amplification methods. For instance, in September 2021, according to data published by ResearchGate, Nucleic Acid Amplification has been mentioned as alternative methods of Polymerase Chain Reaction (PCR). Isothermal amplification methods have been gaining attention, especially for point-of-care diagnosis and applications. These non-PCR based methods have been developed by mimicking the in vivo amplification mechanisms, while performing the amplification with high sensitivity, selectivity and allowing for high-throughput analysis.
Key Players
Major players operating in the global polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Polymerase Chain Reaction Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
- Global Polymerase Chain Reaction Market, By Product Type, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Real Time PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Digital PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Million)
- Reagents and consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Polymerase Chain Reaction Market, By End User, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Clinical Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Academic and Research Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Forensic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Polymerase Chain Reaction Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioMérieux, S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Enzo Life Science, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F.Hoffmann-La Roche Ltd.
- Section
- Research Methodology
- About Us
*Browse 28 market data tables and 34 figures on "Global Polymerase Chain Reaction Market” - forecast to 2030
Detailed Segmentation:
- Global Polymerase Chain Reaction Market, By Product Type:
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- Global Polymerase Chain Reaction Market, By End User:
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- Global Polymerase Chain Reaction Market, By Region:
- North America
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Country
- U.S.
- Canada
- By Product Type
- Latin America
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type
- Europe
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Product Type
- Asia Pacific
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Product Type
- Middle East
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- By Product Type
- Africa
- By Product Type
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents and consumables
- Instruments
- By End User
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Product Type
- North America